System Interventions to Achieve Early and Equitable Transplants Study - Long-Term
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Chronic Kidney Diseases. Basic parameters: 18 years — 75 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
System Interventions to Achieve Early and Equitable Transplants (STEPS) Study (and Long-Term STEPS-LT)
Overview
STEPS-LT is an extension of the System Interventions to Achieve Early and Equitable Transplants (STEPS) study. STEPS-LT will follow participants that previously completed the STEPS study to evaluate sustained behavioral activation and transplant-related milestones among participants.
Detailed description
STEPS-LT extends the original STEPS study for long-term follow-up. Participants will be followed for an additional 36 months to evaluate sustained behavioral activation and transplant-related milestones among participants originally enrolled in STEPS. STEPS-LT maintains the original STEPS study cohort and will collect additional outcomes data through questionnaires, electronic health records, and the Scientific Registry of Transplant Recipients. This extended follow-up will assess participants' engagement in transplant readiness behaviors and transplant barriers they encounter over time.
Primary outcome measures
- Patient Reported Physician Discussions [Time frame: month 6, months 12, months 18, month 24, month 30, month 36]
- Patient Reported Family Discussions [Time frame: month 6, months 12, months 18, month 24, month 30, month 36]
- Patient Reported Initiation of Transplant Evaluation [Time frame: month 6, months 12, months 18, month 24, month 30, month 36]
- Patient Reported Identification of a Living Donor [Time frame: month 6, months 12, months 18, month 24, month 30, month 36]
- Patient Reported Completion of Transplant Evaluation [Time frame: month 6, months 12, months 18, month 24, month 30, month 36]
Secondary outcome measures (7)
- Health System Reported Live Donor Inquires to Transplant Center [Time frame: month 6, months 12, months 18, month 24, month 30, month 36]
- Health System Reported Receipt of Live Donor Kidney Transplant [Time frame: month 6, months 12, months 18, month 24, month 30, month 36]
- Health System Reported Receipt of Deceased Donor Kidney Transplant [Time frame: month 6, months 12, months 18, month 24, month 30, month 36]
- Health System Reported Placement on Deceased Kidney Donor Waitlist [Time frame: month 6, months 12, months 18, month 24, month 30, month 36]
- Health System Reported Completion of Transplant Evaluation [Time frame: month 6, months 12, months 18, month 24, month 30, month 36]
- Health System Reported Initiation of Transplant Evaluation [Time frame: month 6, months 12, months 18, month 24, month 30, month 36]
- Patient Reported Kidney Transplant Knowledge [Time frame: month 6, months 12, months 18, month 24, month 30, month 36]
Eligibility criteria
Inclusion criteria
\- STEPS study participants who did not withdraw consent during the study or have not died.
Exclusion criteria
\- Not previously enrolled in STEPS study
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Case-control
Study locations
United States · 1 center
- Wake Forest University Health Sciences — Winston-Salem
Identifiers
NCT: NCT07515794 · IRB00097407.1 · LTF-2024C2-39695